Limba
Romanian
Romanian
English|
Emapalumab (anti-IFNγ), 1mg*25
19.336,31 RON
SKU
SKM_A2041_1mg*25
Emapalumab (anti-IFNγ), a monoclonal antibody directed against IFNγ, is the first global approval for the treatment of pediatric and adult patients with primary hemophagocytic lymphohistiocytosis (HLH) with refractory.
| Price | 16.249,00 RON (preturile sunt fara TVA) |
|---|---|
| Description |
Emapalumab (anti-IFNγ), a monoclonal antibody directed against IFNγ, is the first global approval for the treatment of pediatric and adult patients with primary hemophagocytic lymphohistiocytosis (HLH) with refractory. |
